Ferrer
PrivateLast Round
Debt
8/10/2020
Total Funding Raised
$412.6M
Company Overview
Ferrer is a pharmaceutical company that develops and delivers therapeutic solutions with a focus on pulmonary vascular and interstitial lung diseases and neurological disorders.
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Ferrer Comps
Public and private peers based on sector, stage, and business model.
Ferrer Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Debt | 8/10/2020 | ||||
| Debt | 12/5/2008 |
Ferrer Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Banca March | Debt |
| European Investment Bank | Debt |
| Deutsche Bank | Debt |
| Banco Bilbao Vizcaya Argentaria | Debt |
Market signals
Structured signals derived from secondary market and firmographic data.
- Oct 27, 2024
Monthly visitors grew 31% MoM, reaching 19.4K.
- Aug 10, 2020
$260M raised from Banco Bilbao Vizcaya Argentaria and CaixaBank.
Ferrer Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Ferrer's valuation, stock price, and market status.